Zai Lab (ZLAB) Operating Expenses (2020 - 2026)
Zai Lab (ZLAB) reported Operating Expenses of $130.7 million for Q1 2026, up 5.24% on a YoY basis from $124.2 million in Q1 2025, and down 2.98% sequentially from $134.7 million in Q4 2025.
Zai Lab (ZLAB) Operating Expenses (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of Operating Expenses data on file, last reported at $130.7 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 5.24% year-over-year to $130.7 million; the trailing twelve-month figure through Mar 2026 stood at $505.0 million (down 5.35% YoY), and the FY2025 full-year result was $498.5 million, down 6.51% from the prior year.
- Operating Expenses retreated to $130.7 million in Q1 2026, from $134.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $166.1 million in Q3 2022 to a low of $110.8 million in Q1 2022.
- A 5-year average of $132.7 million and a median of $130.7 million in 2026 frame the typical range for Operating Expenses.
- Peak annual rise in Operating Expenses reached 45.5% in 2022, while the deepest fall reached 53.75% in 2022.
- Tracing ZLAB's Operating Expenses over 5 years: stood at $139.0 million in 2022, then gained by 18.42% to $164.6 million in 2023, then declined by 18.05% to $134.9 million in 2024, then retreated by 0.15% to $134.7 million in 2025, then decreased by 2.98% to $130.7 million in 2026.
- Business Quant data shows ZLAB's Operating Expenses at $130.7 million in Q1 2026, $134.7 million in Q4 2025, and $118.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 130.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.66 Mn |
| Dec 31, 2025 | 134.67 Mn |
| Sep 30, 2025 | 118.03 Mn |
| Jun 30, 2025 | 121.65 Mn |
| Mar 31, 2025 | 124.15 Mn |
| Dec 31, 2024 | 134.87 Mn |
| Sep 30, 2024 | 133.20 Mn |
| Jun 30, 2024 | 141.34 Mn |
| Mar 31, 2024 | 123.84 Mn |
| Dec 31, 2023 | 164.57 Mn |
| Sep 30, 2023 | 127.32 Mn |
| Jun 30, 2023 | 144.60 Mn |
| Mar 31, 2023 | 110.98 Mn |
| Dec 31, 2022 | 138.97 Mn |
| Sep 30, 2022 | 166.08 Mn |
| Jun 30, 2022 | 129.49 Mn |
| Mar 31, 2022 | 110.85 Mn |
| Dec 31, 2021 | 241.66 Mn |
| Sep 30, 2021 | 114.15 Mn |
| Jun 30, 2021 | 196.64 Mn |